Federation des caisses Desjardins du Quebec’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-127,925	Closed	-$88.3K	–	2559
2020 Q4	$88.3K	Sell	127,925 -4,839	-4%	-$10.3K	﹤0.01%	1330
2020 Q3	$299K	Buy	132,764 +284	+0.2%	+$811	﹤0.01%	772
2020 Q2	$474K	Buy	132,480 +489	+0.4%	+$1.76K	0.01%	664
2020 Q1	$502K	Buy	131,991 +15,751	+14%	+$51.9K	0.01%	642
2019 Q4	$350K	Buy	+116,240	New	+$302K	﹤0.01%	873

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's BMY.RT Position: Q1 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 127,925 shares — an estimated $88.3K sold.

Federation des caisses Desjardins du Quebec first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $502K in Q1 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Federation des caisses Desjardins du Quebec reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 127,925 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $88.3K.
Federation des caisses Desjardins du Quebec first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Federation des caisses Desjardins du Quebec's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $502K in Q1 2020.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2021, filed 30 Aug 2024.